Platelets Levels before and after Surgical Intervention in Patients with Oral and Maxillofacial Tumors at MNH, Tanzania
Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53229#.VLhy0MnQrzE
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53229#.VLhy0MnQrzE
Affiliation(s)
1Department of Oral and Maxillofacial Surgery, MUHAS, Dar es Salaam, Tanzania.
2Department of Oral and Maxillofacial Surgery, MNH, Dar es Salaam, Tanzania.
2Department of Oral and Maxillofacial Surgery, MNH, Dar es Salaam, Tanzania.
ABSTRACT
Background:
There are documented effects of platelets on the solid tumors which
need further study. The elevated platelet counts have been described for
majority of cancers. There is inadequate information of effect of
benign and malignant oral and maxillofacial tumors on the regulation of
platelets. The aim of this study was to investigate the changes in
platelet counts among patients with oral and maxillofacial benign and
malignant tumors following surgical interventions. Methods: A
descriptive postoperative study was done whereby patients with benign
and malignant oral and maxillofacial tumors who met the inclusion
criteria were included. The included patients were those who had no
history of blood transfusion prior, during or after surgery, not on
haemoglobin-boosting or bone marrow suppressing medications, not
seropositive to human immunodeficiency virus also without clinical
findings suggestive of lymphadenopathy, splenomegaly, ecchymosis and
petechiae. Demographic data, Platelet counts and haemoglobin levels
before and after surgery were documented and analysed by chi-square test
and values were considered to be significant if p < 0.05. Results: A
total of 61 patients were included in the study. The mean age of
participants was 37.03 ± 16.6 years with range of 7 to 77 years.
Majority 82.5% (n = 52) had benign tumors with a leading diagnosis of
ameloblastoma followed by ossifying fibroma. In general there was an
increase of platelet counts following surgery from the mean of 276.38 ±
109.40 K/uL to 308.51 ± 117.24 K/uL. Looking at benign and malignant
separately, following surgery there was an increase of platelet counts
for benign tumors (278.87 ± 106.37 to 305.96 ± 123.12) but a decrease
for malignant tumors group (282.33 ± 147.03 to 232 ± 78.48). The
haemoglobin level changed from the mean of 12.60 ± 1.71 g/dl before
surgery to 11.69 ± 1.70 g/dl after surgery. Conclusion: The mean
postoperative increase in platelet counts in benign and malignant tumors
was due to healing process of the wound following surgery while the
postoperative decrease in platelets counts in malignant tumors was due
to effect of tumor removal which diminished the production of platelets
activating factors. Malignant tumors produce platelets activating
factors which are necessary for them to grow. Also, the difference in
postoperative platelets counts in benign and malignant oral and
maxillofacial tumors could be attributed by different biological
behavior of benign and malignant tumors and hence different interactions
of platelets to these tumors.
Cite this paper
References
Moshy,
J. , Sohal, K. , Owibingire, S. and Augustino, A. (2015) Platelets
Levels before and after Surgical Intervention in Patients with Oral and
Maxillofacial Tumors at MNH, Tanzania. Surgical Science, 6, 7-11. doi: 10.4236/ss.2015.61002.
| [1] | Buergy, D., Wenz, F., Groden, C. and Brookman, M.A. (2012) Tumor-Platelet Interaction in Solid Tumors. International Journal of Cancer, 130, 2747-2760. http://dx.doi.org/10.1002/ijc.27441 |
| [2] | Ho-Tin-Noé, B., George, T. and Wegner, D.D. (2009) Platelets: Guardians of Tumor Vasculature. Cancer Research, 69, 5623-5626. http://dx.doi.org/10.1158/0008-5472.CAN-09-1370 |
| [3] | Nash, G.F., Turner, L.F., Scully, M.F. and Kakkar, A.K. (2002) Platelets and Cancer. The Lancet Oncology, 3, 425-430. http://dx.doi.org/10.1016/S1470-2045(02)00789-1 |
| [4] | Pinedo, H.M., Verheul, H.M., D’Amato, R.J. and Folkman, J. (1998) Involvement of Platelets in Tumor Angiogenesis. The Lancet, 352, 1775-1777. http://dx.doi.org/10.1016/S0140-6736(98)05095-8 |
| [5] | Zur, R.L. (1872) Pathologischen des Blutes. Arch Anatphysiol Wissesch Med, 39, 237-249. |
| [6] | Billroth, T. (1978) Lectures on Surgical Pathology and Therapeutics: A Handbook for Students and Practitionersed. The New Sydenham Society, London. |
| [7] | Dominguezi, I., Crippa, S., Thayer, S.P., Hung, Y.P., Ferron, C.R., Warshaw, A.L. and Fernandez-Del, C.C. (2008) Peoperative Platelet Count and Survival Prognosis in Resected Pancreatic Ductal Carcinoma. World Journal of Surgery, 32, 1051-1056. |
| [8] | Bambace, N.M. and Holmes, C.E. (2011) The Platelet Contribution to Cancer Progression. Journal of Thrombosis and Haemostasis, 9, 237-249. http://dx.doi.org/10.1111/j.1538-7836.2010.04131.x |
| [9] | Pretramaggiori, G., Scherer, S.S., Cervi, D., Klement, G. and Orgill, D.P. (2008) Tumors Stimulate Platelets Delivery of Angiogenic Factors in Vitro: An Unexpected Benefit. American Journal of Pathology, 173, 1609-1616. http://dx.doi.org/10.2353/ajpath.2008.080474 |
| [10] | Sun, N.C., Mcfee, W.M., Hum, G.J. and Weiner, J.M. (1979) Haemostatic Abnormalities in Malignancy; A Prospective Study of One Hundred Eight Patients. Part I. Coagulation Studies. American Journal of Clinical Pathology, 71, 10-16. |
| [11] | Blom,
J.W., Vanderschoot, J.P.M., Oostinder, M.J., Osanto, S., Van Der Meer,
F.J.M. and Rosendaa, F.R. (2006) Incidence of Venous Thrombosis in a
Large Cohort of 66,329 Cancer Patients: Results of a Record Linkage
Study. Journal of Thrombosis and Haemostasis, 4, 529-535. http://dx.doi.org/10.1111/j.1538-7836.2006.01804.x |
| [12] | Manegold,
P.C., Hutter, J., Pahemik, S.A., Messmer, K. and Delliani, M. (2003)
Platelet-Endothelial Interaction in Tumor Angiogenesis and
Microcirculation. Blood, 101, 1970-1976. http://dx.doi.org/10.1182/blood.V101.5.1970 eww150115lx |
评论
发表评论